rss Posted October 20, 2021 Report Posted October 20, 2021 Clin Exp Dermatol. 2021 Oct 20. doi: 10.1111/ced.14987. Online ahead of print.ABSTRACTFor several decades, there has been a significant growth in the incidence of autoimmune diseases. Studies indicate that genetic factors may not be the only trigger for disease development and that dysbiosis of the microbiome may be another mechanism involved in the pathogenesis of autoimmune diseases. The role of the microbiome in the development of common skin disorders such as psoriasis, atopic dermatitis, acne, and rosacea is increasingly well understood. However, few studies have focused on lichen planus and the rare acquired immunobullous diseases (AIBD), both mucocutaneous groups of disorders linked to skin, oral and gut microbiomes. This review provides an insight into the current understanding of how the microbiome may contribute to the development of autoimmunity as well as themaintenance and exacerbation of acquired immunobullous and lichenoid diseases. These mechanisms may have implications for future preventive and therapeutic approaches.PMID:34669983 | DOI:10.1111/ced.14987{url} = URL to article
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now